SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 61 filers reported holding SUTRO BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65,704 | -53.2% | 18,935 | -37.2% | 0.00% | -55.6% |
Q2 2023 | $140,300 | -1.4% | 30,172 | -2.0% | 0.01% | 0.0% |
Q1 2023 | $142,241 | -8.6% | 30,788 | +59.9% | 0.01% | +12.5% |
Q4 2022 | $155,597 | +2122.8% | 19,257 | +2651.0% | 0.01% | – |
Q3 2020 | $7,000 | +133.3% | 700 | +75.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 400 | +33.3% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | -75.0% | 300 | -77.1% | 0.00% | -100.0% |
Q3 2019 | $12,000 | +20.0% | 1,312 | +44.2% | 0.00% | – |
Q2 2019 | $10,000 | – | 910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |